Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

999 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Active, Not Recruiting

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

NCT02521844

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • University of Arizona Cancer Center, 3838 N. Campbell Avenue, RM 2111, Site 203 Tucson, Arizona, United States
  • Chao Family Comprehensive Cancer Center,Stern Center for Cancer Clinical Trials and Research, 101 City Drive South, Site 209 Orange, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavilion, 12648 East 17th Avenue; MSF 700, Site 202 Aurora, Colorado, United States
  • University of Kansas Medical Center, 4350 Shawnee Mission Parkway, Suite 2310, MS 6004, Site 210 Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

NCT04652076

Conditions
Cervix Carcinoma, Endometrial Carcinoma, Endometrial Neoplasms, +13 more
Locations
  • CHRU BESANCON - Hopital Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre François Baclesse Caen, France
  • Centre Georges François Leclerc Dijon, France
View all 15 locations
View Trial Details
Active, Not Recruiting

The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma

NCT01820858

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Qilu Hospital，Shandong University Jinan, Shandong, China
  • Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma

NCT01820884

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Qilu Hospital，Shandong University Jinan, Shandong, China
  • Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

NCT03469674

Conditions
Endometrial Cancer Stage I, Endometrial Cancer Stage II, Endometrial Neoplasms, +11 more
Locations
  • Medical University, Vienna Vienna, Austria
  • University Hospital Gent Ghent, Belgium
  • CEEGOG, General Faculty Hospital and First Faculty of Medicine, Charles University, Prague Prague, Czechia
  • GINECO group - Institut Goustave Roussy Paris, France
View all 31 locations
View Trial Details

Related conditions